RxDoctor Payments Data

Michelle Morris, NP

Family · Stratford, NJNPI 1043872542

Payments from drug & device makers

$309in general payments, 2019–2025

Across 17 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$65
  • Johnson & Johnson$54
  • Neurocrine Biosciences, Inc.$51
  • Boston Scientific$49
  • Alkermes, Inc.$31
  • Gilead$18
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$309100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$309 in reported general payments places this provider in the 50th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Medicare billing

Part B allowed, 2024
$3,194
Medicare patients
32
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate145$495,260
IngrezzaValbenazine Tosylate23$187,111
AristadaAripiprazole Lauroxil56$182,035
Abilify MaintenaAripiprazole48$121,236
RexultiBrexpiprazole68$82,502
CaplytaLumateperone Tosylate37$57,771
VraylarCariprazine Hcl19$28,758
Clozapine184$19,756
Paliperidone ErPaliperidone137$17,386
Divalproex Sodium ErDivalproex Sodium194$10,074
TrintellixVortioxetine Hydrobromide17$7,830
Olanzapine249$7,671
Aripiprazole167$6,716
Risperidone286$6,576
Benztropine Mesylate495$6,350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$54$495,260145 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$65$203,738116 claims
Neurocrine Biosciences, Inc.Ingrezza$51$187,11123 claims
Alkermes, Inc.Aristada$31$182,03556 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$14$57,77137 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,692 family providers in New Jersey.

Other family in Stratford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →